Stocks › UTHR

UNITED THERAPEUTICS Corp

UTHR·Nasdaq·United States United States·USD
$554.73
-4.37 (-0.78%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
UTHR
UNITED THERAPEUTICS Corp · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
UTHRS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of UTHR by members of U.S. Congress · 52 on record · 3 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Lisa C. McClainLisa C. McClainHouse · R · MI UTHRUNITED THERAPEUTICS Corp · Stock Sale
$1,001 - $15,000
Nov 21, 2025 Oct 31, 2025 Filing ↗
Lisa C. McClainLisa C. McClainHouse · R · MI UTHRUNITED THERAPEUTICS Corp · Stock Purchase
$1,001 - $15,000
Nov 21, 2025 Oct 30, 2025 Filing ↗
Lisa C. McClainLisa C. McClainHouse · R · MI UTHRUNITED THERAPEUTICS Corp · Stock Sale
$1,001 - $15,000
Nov 21, 2025 Oct 30, 2025 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Sale
$15,001 - $50,000
Nov 10, 2025 Oct 27, 2025 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Sale
$50,001 - $100,000
Sep 11, 2025 Aug 22, 2025 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Purchase
$50,001 - $100,000
Sep 11, 2025 Aug 7, 2025 Filing ↗
Lisa C. McClainLisa C. McClainHouse · R · MI UTHRUNITED THERAPEUTICS Corp · Stock Purchase
$1,001 - $15,000
Aug 13, 2025 Jun 11, 2025 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Sale
$100,001 - $250,000
Jul 7, 2025 Jun 27, 2025 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Sale
$100,001 - $250,000
Jan 15, 2025 Dec 13, 2024 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Sale
$15,001 - $50,000
Jan 15, 2025 Dec 13, 2024 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Sale
$250,001 - $500,000
Dec 16, 2024 Nov 19, 2024 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Sale
$1,001 - $15,000
Dec 16, 2024 Nov 6, 2024 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Sale
$15,001 - $50,000
Dec 16, 2024 Nov 6, 2024 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Sale
$50,001 - $100,000
Dec 16, 2024 Nov 20, 2024 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Sale
$15,001 - $50,000
Dec 16, 2024 Nov 19, 2024 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Sale
$15,001 - $50,000
Dec 16, 2024 Nov 20, 2024 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Sale
$15,001 - $50,000
Jan 12, 2024 Dec 7, 2023 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Sale
$1,001 - $15,000
Jan 12, 2024 Dec 7, 2023 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Sale
$100,001 - $250,000
Jun 22, 2023 May 12, 2023 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Sale
$15,001 - $50,000
Jun 22, 2023 May 12, 2023 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Purchase
$1,001 - $15,000
Apr 18, 2022 Mar 1, 2022 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Purchase
$15,001 - $50,000
Apr 18, 2022 Mar 1, 2022 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Sale
$15,001 - $50,000
Feb 23, 2022 Jan 28, 2022 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Sale
$1,001 - $15,000
Feb 23, 2022 Jan 28, 2022 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX UTHRUNITED THERAPEUTICS Corp · Stock Sale
$15,001 - $50,000
Jan 27, 2022 Dec 23, 2021 Filing ↗

Whale Activity

Position changes in UTHR reported for 2026-09-30 by 962 institutional filers
Increased: 281New: 79Held: 129Decreased: 326Closed: 113No prior filing: 34
  • Increased281
  • New79
  • Held129
  • Decreased326
  • Closed113
  • No prior filing34
FilerSharesValueChange
BlackRock, Inc.5.6M$3.02Bincreased
Avoro Capital Advisors LLC2.8M$1.49Bdecreased
STATE STREET CORP2.0M$1.06Bincreased
VANGUARD CAPITAL MANAGEMENT LLC1.9M$1.05Bincreased
VANGUARD PORTFOLIO MANAGEMENT LLC1.9M$1.04Bdecreased
WELLINGTON MANAGEMENT GROUP LLP1.9M$1.03Bincreased
RENAISSANCE TECHNOLOGIES LLC1.7M$908.2Mdecreased
Amundi988.8K$535.8Mincreased
GEODE CAPITAL MANAGEMENT, LLC975.0K$527.2Mdecreased
CITADEL ADVISORS LLC928.5K$503.1Mincreased
Invesco Ltd.806.3K$436.9Mincreased
Janus Henderson Group Ltd.773.2K$418.9M—

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by UTHR insiders, by quarter · Form 4
-1.0M-500.0K0500.0K1.0M2025 Q1: -121.7K2025 Q12025 Q2: -117.2K2025 Q22025 Q3: -251.4K2025 Q32025 Q4: -723.8K2025 Q42026 Q1: -475.1K2026 Q12026 Q2: -881.7K2026 Q22026 Q3: -648.9K2026 Q32026 Q4: -240.5K2026 Q4

Recent Insider Transactions

10,375 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
MAHON PAUL AEVP & GENERAL COUNSEL Sale −76 $563.22 $43K Nov 19, 2026 Form 4 ↗
MAHON PAUL AEVP & GENERAL COUNSEL Sale −756 $570.73 $431K Nov 19, 2026 Form 4 ↗
MAHON PAUL AEVP & GENERAL COUNSEL Sale −700 $569.68 $399K Nov 19, 2026 Form 4 ↗
MAHON PAUL AEVP & GENERAL COUNSEL Sale −69 $564.44 $39K Nov 19, 2026 Form 4 ↗
MAHON PAUL AEVP & GENERAL COUNSEL Sale −655 $565.63 $370K Nov 19, 2026 Form 4 ↗
MAHON PAUL AEVP & GENERAL COUNSEL Sale −601 $572.70 $344K Nov 19, 2026 Form 4 ↗
MAHON PAUL AEVP & GENERAL COUNSEL Sale −561 $573.79 $322K Nov 19, 2026 Form 4 ↗
MAHON PAUL AEVP & GENERAL COUNSEL Sale −523 $557.46 $292K Nov 19, 2026 Form 4 ↗
MAHON PAUL AEVP & GENERAL COUNSEL Sale −464 $571.79 $265K Nov 19, 2026 Form 4 ↗
MAHON PAUL AEVP & GENERAL COUNSEL Sale −440 $554.73 $244K Nov 19, 2026 Form 4 ↗
MAHON PAUL AEVP & GENERAL COUNSEL Sale −400 $559.50 $224K Nov 19, 2026 Form 4 ↗
MAHON PAUL AEVP & GENERAL COUNSEL Sale −378 $558.49 $211K Nov 19, 2026 Form 4 ↗
MAHON PAUL AEVP & GENERAL COUNSEL Sale −300 $568.62 $171K Nov 19, 2026 Form 4 ↗
MAHON PAUL AEVP & GENERAL COUNSEL Sale −300 $561.78 $169K Nov 19, 2026 Form 4 ↗
MAHON PAUL AEVP & GENERAL COUNSEL Sale −200 $566.91 $113K Nov 19, 2026 Form 4 ↗
MAHON PAUL AEVP & GENERAL COUNSEL Sale −197 $560.63 $110K Nov 19, 2026 Form 4 ↗
MAHON PAUL AEVP & GENERAL COUNSEL Sale −192 $574.75 $110K Nov 19, 2026 Form 4 ↗
MAHON PAUL AEVP & GENERAL COUNSEL Sale −134 $575.93 $77K Nov 19, 2026 Form 4 ↗
MAHON PAUL AEVP & GENERAL COUNSEL Sale −1,240 $556.07 $690K Nov 19, 2026 Form 4 ↗
MAHON PAUL AEVP & GENERAL COUNSEL Sale −114 $577.19 $66K Nov 19, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding UTHR · SEC Form N-PORT
FundSharesValue% of fundAs of
iShares Core S&P Mid-Cap ETF
iShares Trust
1.5M$787.1M0.63%Jun 30, 2026
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
1.3M$730.2M0.03%Jun 30, 2026
VANGUARD SMALL-CAP INDEX FUND
VANGUARD INDEX FUNDS
973.5K$527.5M0.28%Jun 30, 2026
VANGUARD HEALTH CARE FUND
VANGUARD SPECIALIZED FUNDS
719.4K$372.4M0.98%Jul 31, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
486.6K$263.6M0.27%Jun 30, 2026
State Street SPDR S&P MidCap 400SM ETF Trust
SPDR S&P MIDCAP 400 ETF TRUST
326.6K$176.9M0.63%Jun 30, 2026
VANGUARD SMALL-CAP VALUE INDEX FUND
VANGUARD INDEX FUNDS
308.3K$167.1M0.25%Jun 30, 2026
iShares Biotechnology ETF
iShares Trust
290.8K$157.6M1.73%Jun 30, 2026
VANGUARD SMALL-CAP GROWTH INDEX FUND
VANGUARD INDEX FUNDS
280.8K$152.1M0.32%Jun 30, 2026
Invesco S&P MidCap Quality ETF
Invesco Exchange-Traded Fund Trust
266.2K$137.8M2.53%Jul 31, 2026

Mutual funds and ETFs whose N-PORT filings list UTHR's shares (CUSIP 91307C102), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Martine A. RothblattSCHEDULE 13G/A · passive (13G) · 1.7M shares4.0%
    Nov 4, 2026 · ↗
  • ROTHBLATT MARTINE ASCHEDULE 13G/A · passive (13G) · 2.3M shares5.3%
    Aug 14, 2026 · ↗
  • Wellington Investment Advisors Holdings LLPSCHEDULE 13G/A · passive (13G) · 1.4M shares3.2%
    Aug 13, 2026 · ↗
  • Wellington Group Holdings LLPSCHEDULE 13G/A · passive (13G) · 1.4M shares3.2%
    Aug 13, 2026 · ↗
  • Wellington Management Group LLPSCHEDULE 13G/A · passive (13G) · 1.4M shares3.2%
    Aug 13, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming united therapeutics as client
$0$63K$125K$188K$250K2025 Q3: $20K2025 Q4: $60K20252026 Q1: $80K2026 Q2: $80K2026 Q3: $80K2026
  • TIBER CREEK GROUPUNITED THERAPEUTICS CORPORATION · 2026 Q3 · HCR$80K
    Filing ↗
  • TIBER CREEK GROUPUNITED THERAPEUTICS CORPORATION · 2026 Q2 · HCR$80K
    Filing ↗
  • TIBER CREEK GROUPUNITED THERAPEUTICS CORPORATION · 2026 Q1 · HCR$80K
    Filing ↗
  • TIBER CREEK GROUPUNITED THERAPEUTICS CORPORATION · 2025 Q4 · POS$60K
    Filing ↗
  • TIBER CREEK GROUPUNITED THERAPEUTICS CORPORATION · 2025 Q3$20K
    Filing ↗

Government Contracts

Federal awards to united therapeutics · USAspending
$200KAwarded · 11 contracts on record
  • Department of Veterans AffairsTYVASO 0.6 MG REFILL KIT$30K
    Aug 27, 2025 · ↗
  • Department of Veterans AffairsTYVASO 0.6 MG REFILL KIT$0
    Apr 8, 2026 · ↗
  • Department of Veterans AffairsTYVASO 0.6 MG REFILL KIT$16K
    Jul 21, 2026 · ↗
  • Department of Veterans AffairsTYVASO 64 MCG KIT$17K
    Jul 16, 2026 · ↗
  • Department of Veterans AffairsTYVASO 64 MCG KIT$17K
    Jul 9, 2026 · ↗
  • Department of Veterans AffairsTYVASO 64 MCG KIT$17K
    Jun 25, 2026 · ↗
  • Department of Veterans AffairsTYVASO 64 MCG KIT$17K
    Jun 11, 2026 · ↗
  • Department of Veterans AffairsTYVASO 64 MCG$17K
    Jun 5, 2026 · ↗

U.S. Patents

Recent USPTO applications naming UNITED THERAPEUTICS Corp

No USPTO patent applications found for UNITED THERAPEUTICS Corp.

Annual Financials

From UTHR's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$3.18B$2.88B$2.33B$1.94B$1.69B
Operating income$1.49B$1.38B$1.18B$979.7M$555.9M
Net income$1.33B$1.20B$984.8M$727.3M$475.8M
Diluted EPS$27.86$24.64$19.81$15.00$10.06
Operating cash flow$1.56B$1.33B$978.0M$802.5M$598.2M
Cash and equivalents$1.56B$1.70B$1.21B$961.2M$894.8M
Total assets$7.88B$7.36B$7.17B$6.04B$5.17B
Total liabilities$783.8M$920.0M$1.18B$1.25B$1.21B
Shareholders' equity$7.10B$6.44B$5.98B$4.80B$3.96B

As UNITED THERAPEUTICS Corp tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 25, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 2-for-1Stock splitSep 23, 2009

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 9.01Results of operationsNov 4, 2026
    EDGAR ↗
  • 8-K · Items 8.01, 9.01Other eventsOct 22, 2026
    EDGAR ↗
  • 8-K · Items 8.01, 9.01Other eventsOct 14, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 7.01, 9.01Material agreement · Reg FD disclosureSep 8, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 5, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureJul 23, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 5.07, 9.01Officer / director change · Shareholder voteJun 29, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsMay 6, 2026
    EDGAR ↗

About UNITED THERAPEUTICS Corp

From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersSILVER SPRING, MD
IncorporatedDE